Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia

TY Chang, CC Dvorak, ML Loh - Blood, The Journal of the …, 2014 - ashpublications.org
Juvenile myelomonocytic leukemia (JMML) is a typically aggressive myeloid neoplasm of
childhood that is clinically characterized by overproduction of monocytic cells that can …

[HTML][HTML] Molecular targeted therapy and immunotherapy for myelodysplastic syndrome

P Lee, R Yim, Y Yung, HT Chu, PK Yip… - International Journal of …, 2021 - mdpi.com
Myelodysplastic syndrome (MDS) is a heterogeneous, clonal hematological disorder
characterized by ineffective hematopoiesis, cytopenia, morphologic dysplasia, and …

[HTML][HTML] Inherited and somatic defects in DDX41 in myeloid neoplasms

C Polprasert, I Schulze, MA Sekeres, H Makishima… - Cancer cell, 2015 - cell.com
Most cases of adult myeloid neoplasms are routinely assumed to be sporadic. Here, we
describe an adult familial acute myeloid leukemia (AML) syndrome caused by germline …

Aging drives Tet2+/− clonal hematopoiesis via IL-1 signaling

F Caiado, LV Kovtonyuk, NG Gonullu, J Fullin… - Blood, 2023 - ashpublications.org
Clonal hematopoiesis of indeterminate potential (CHIP), also referred to as aging-related
clonal hematopoiesis, is defined as an asymptomatic clonal expansion of mutant mature …

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia

R Piazza, S Valletta, N Winkelmann, S Redaelli… - Nature …, 2013 - nature.com
Atypical chronic myeloid leukemia (aCML) shares clinical and laboratory features with CML,
but it lacks the BCR-ABL1 fusion. We performed exome sequencing of eight aCMLs and …

Somatic SETBP1 mutations in myeloid malignancies

H Makishima, K Yoshida, N Nguyen, B Przychodzen… - Nature …, 2013 - nature.com
Here we report whole-exome sequencing of individuals with various myeloid malignancies
and identify recurrent somatic mutations in SETBP1, consistent with a recent report on …

SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i (17)(q10) …

M Meggendorfer, U Bacher, T Alpermann, C Haferlach… - Leukemia, 2013 - nature.com
Chronic myeloid malignancies are categorized to the three main categories
myeloproliferative neoplasms (MPNs), myelodysplastic syndromes (MDSs) and MDS/MPN …

[HTML][HTML] SETBP1 accumulation induces P53 inhibition and genotoxic stress in neural progenitors underlying neurodegeneration in Schinzel-Giedion syndrome

F Banfi, A Rubio, M Zaghi, L Massimino… - Nature …, 2021 - nature.com
The investigation of genetic forms of juvenile neurodegeneration could shed light on the
causative mechanisms of neuronal loss. Schinzel-Giedion syndrome (SGS) is a fatal …

[HTML][HTML] An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of …

TI Mughal, NCP Cross, E Padron, RV Tiu… - …, 2015 - ncbi.nlm.nih.gov
In the 2008 WHO classification, chronic myeloid malignancies that share both
myelodysplastic and myeloproliferative features define the myelodysplastic …

SETBP1 is dispensable for normal and malignant hematopoiesis

A Tanaka, K Nishimura, W Saika, A Kon, Y Koike… - Leukemia, 2023 - nature.com
SETBP1 is a potential epigenetic regulator whose hotspot mutations preventing proteasomal
degradation are recurrently detected in myeloid malignancies with poor prognosis. It is …